دورية أكاديمية
أعرض في EDS

NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.

التفاصيل البيبلوغرافية
العنوان: NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.
المؤلفون: Yun O; Médecins Sans Frontières/Doctors Without Borders, New York, New York, USA. oliver.yun@newyork.msf.org, Priotto G, Tong J, Flevaud L, Chappuis F
المصدر: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2010 May 25; Vol. 4 (5), pp. e720. Date of Electronic Publication: 2010 May 25.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: Electronic Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Endemic Diseases*, Antiprotozoal Agents/*therapeutic use , Eflornithine/*therapeutic use , Nifurtimox/*therapeutic use , Trypanosoma brucei gambiense/*drug effects , Trypanosomiasis, African/*drug therapy , Trypanosomiasis, African/*epidemiology, Africa South of the Sahara/epidemiology ; Antiprotozoal Agents/adverse effects ; Drug Therapy, Combination ; Eflornithine/adverse effects ; Humans ; Nifurtimox/adverse effects
Number of References: 34
References: Lancet. 2010 Jan 9;375(9709):160-5. (PMID: 20109893)
PLoS Negl Trop Dis. 2007 Nov 07;1(2):e64. (PMID: 18060083)
Lancet. 2009 Jul 4;374(9683):7-9. (PMID: 19559477)
J Infect Dis. 2010 Feb 1;201(3):453-63. (PMID: 20047500)
World Health Organ Tech Rep Ser. 1998;881:I-VI, 1-114. (PMID: 10070249)
Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):254-6. (PMID: 1412646)
J Infect Dis. 2005 Jun 1;191(11):1922-31. (PMID: 15871127)
PLoS Med. 2008 Feb;5(2):e55. (PMID: 18303943)
Emerg Infect Dis. 2010 Feb;16(2):354-6. (PMID: 20113585)
PLoS Clin Trials. 2006 Dec 08;1(8):e39. (PMID: 17160135)
Trop Med Int Health. 2008 Feb;13(2):265-71. (PMID: 18304274)
Br J Pharmacol. 2007 Dec;152(8):1155-71. (PMID: 17618313)
Afr J Health Sci. 2005 Jan-Jun;12(1-2):i-ii. (PMID: 17298132)
Ann Soc Belg Med Trop. 1984 Mar;64(1):37-43. (PMID: 6732304)
Emerg Infect Dis. 2007 Oct;13(10):1484-90. (PMID: 18257991)
Trop Med Int Health. 2005 Apr;10(4):347-56. (PMID: 15807799)
Lancet. 2009 Jul 4;374(9683):56-64. (PMID: 19559476)
Clin Infect Dis. 2007 Dec 1;45(11):1435-42. (PMID: 17990225)
Lancet. 2010 Jan 9;375(9709):148-59. (PMID: 19833383)
Trop Med Int Health. 2001 May;6(5):412-20. (PMID: 11348536)
Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):439-42. (PMID: 10674099)
N Engl J Med. 2007 Sep 6;357(10):1018-27. (PMID: 17804846)
Wkly Epidemiol Rec. 2006 Feb 24;81(8):71-80. (PMID: 16673459)
Ann Soc Belg Med Trop. 1977;57(4-5):475-80. (PMID: 345982)
Trans R Soc Trop Med Hyg. 1995 Jan-Feb;89(1):92-7. (PMID: 7747321)
المشرفين على المادة: 0 (Antiprotozoal Agents)
M84I3K7C2O (Nifurtimox)
ZQN1G5V6SR (Eflornithine)
تواريخ الأحداث: Date Created: 20100604 Date Completed: 20100806 Latest Revision: 20240324
رمز التحديث: 20240324
مُعرف محوري في PubMed: PMC2876135
DOI: 10.1371/journal.pntd.0000720
PMID: 20520803
قاعدة البيانات: MEDLINE
الوصف
تدمد:1935-2735
DOI:10.1371/journal.pntd.0000720